Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2072studies shown
Showing 97-108 of 2,072
Drug study icon
RecruitingNCT05304767

Safety study of KarXT in schizophrenia

This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.

Multiple locations, including Phoenix
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05823532

Anti-Inflammatory Challenge in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In Atlanta
SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Drug study icon
RecruitingNCT06562608

Anticholinergic Deprescription in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In Pittsburgh
SchizophreniaDrugFrom 40 Years to 70 Years
Countries
United States
Sponsor
Deepak K. Sarpal, M.D.
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research